Nisterime
![]() | |
| Clinical data | |
|---|---|
| Other names | 2α-Chloro-5α-androstan-17β-ol-3-one 3-O-(p-nitrophenyl)oxime; 2α-Chloro-4,5α-dihydrotestosterone 3-O-(p-nitrophenyl)oxime; 2α-Chloro-3-(p-nitrophenoxy)imino-5α-androstan-17β-ol |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C25H33ClN2O4 |
| Molar mass | 461.00 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Nisterime (INN), also known as 2α-chloro-4,5α-dihydrotestosterone 3-O-(p-nitrophenyl)oxime or as 2α-chloro-5α-androstan-17β-ol-3-one 3-O-(p-nitrophenyl)oxime, is a synthetic anabolic-androgenic steroid (AAS) and a derivative of dihydrotestosterone (DHT) that was never marketed.[1] The C17α acetate ester of nisterime, nisterime acetate (ORF-9326), also exists and was developed as a postcoital contraceptive but was similarly never marketed.[1]
See also
References
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 876–. ISBN 978-1-4757-2085-3.
